Dr. E. Voets
ActiveSummary
Dr. E. Voets has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €505k and a net result of €207k. Equity is growing by ~9.7% per year across the filed fiscal years. Its solvency ranks better than 32% of 16618 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability89▲+10
Solvency65▲+1
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40k at 30 days acceptable
Liquidity ample (current ratio 3.5 against 4.73 in 2024; short-term debt: 21.2% and cash: 58% of total assets), but 60.5% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
39.5%
Return on assets
16.2%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-06-2026, 58 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
58 d early
2024
34 d early
2023
44 d early
2022
28 d early
2021
6 d early
2020
43 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€505k=
2024 · €505k
2020: €261klowest in 6 years
2021: €331k▲ +26.9% vs 2020
2022: €505k▲ +52.7% vs 2021highest in 6 years
2023: €505k● 0.0% vs 2022highest in 6 years
2024: €505k● 0.0% vs 2023highest in 6 years
2025: €505k● 0.0% vs 2024highest in 6 years
2020 → 2025
Total assets
€1.28M▼ 0.1%
2024 · €1.28M
2020: €1.69Mhighest in 6 years
2021: €1.59M▼ -6.2% vs 2020
2022: €1.39M▼ -12.4% vs 2021
2023: €1.34M▼ -3.7% vs 2022
2024: €1.28M▼ -4.4% vs 2023
2025: €1.28M▼ -0.1% vs 2024lowest in 6 years
2020 → 2025
Net result
€207k▲ 96.1%
2024 · €105k
2020: €256khighest in 6 years
2021: €70k▼ -72.6% vs 2020lowest in 6 years
2022: €174k▲ +149% vs 2021
2023: €173k▼ -0.8% vs 2022
2024: €105k▼ -39.0% vs 2023
2025: €207k▲ +96.1% vs 2024
2020 → 2025
Working capital
€678k▲ 18.3%
2024 · €573k
2020: €450k
2021: €574k▲ +27.6% vs 2020
2022: €415k▼ -27.7% vs 2021lowest in 6 years
2023: €439k▲ +5.7% vs 2022
2024: €573k▲ +30.5% vs 2023
2025: €678k▲ +18.3% vs 2024highest in 6 years
2020 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€331k-€505k▲ 52.7%€505k=€505k=€505k=
2021: €331klowest in 5 years
2022: €505k▲ +52.7% vs 2021highest in 5 years
2023: €505k● 0.0% vs 2022highest in 5 years
2024: €505k● 0.0% vs 2023highest in 5 years
2025: €505k● 0.0% vs 2024highest in 5 years
Operating result€158k-€301k▲ 89.8%€272k▼ 9.6%€191k▼ 29.9%€322k▲ 69.1%
2021: €158klowest in 5 years
2022: €301k▲ +89.8% vs 2021
2023: €272k▼ -9.6% vs 2022
2024: €191k▼ -29.9% vs 2023
2025: €322k▲ +69.1% vs 2024highest in 5 years
Net result€70k-€174k▲ 149%€173k▼ 0.8%€105k▼ 39.0%€207k▲ 96.1%
2021: €70klowest in 5 years
2022: €174k▲ +149% vs 2021
2023: €173k▼ -0.8% vs 2022
2024: €105k▼ -39.0% vs 2023
2025: €207k▲ +96.1% vs 2024highest in 5 years
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 69% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.28M
Fixed assets
€328k ▼ 40.5%
Current assets
€949k ▲ 30.6%
Equity and liabilities €1.28M
Equity
€505k =
Debt
€772k ▼ 0.2%
Debt's share of the balance-sheet total stays at 60.5%.
Key figures and ratios
EBITDA
€559k▲
2024 · €419k
Cash flow
€443k▲
2024 · €334k
Current ratio
3.50▼
2024 · 4.73
Debt to equity
1.53▼
2024 · 1.53
ROE
40.9%▲
2024 · 20.9%
ROA
16.2%▲
2024 · 8.2%
Interest coverage
13.88▲
2024 · 8.66
Debt ≤ 1 year
€271k▲
2024 · €153k
Debt > 1 year
€500k▼
2024 · €585k
Income taxes
€76k▲
2024 · €43k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 45 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.28M€1.28M▼
Fixed assets21/28€552k€328k▼
Intangible fixed assets21€373k€189k▼
Tangible fixed assets22/27€179k€139k▼
Furniture and vehicles24€169k€132k▼
Other tangible fixed assets26€10k€7k▼
Current assets29/58€726k€949k▲
Amounts receivable within one year40/41€34k-
Trade receivables40€495-
Other amounts receivable41€34k-
Current investments50/53€202k-
Cash at bank and in hand54/58€305k€741k▲
Deferred charges and accrued income490/1€184k€208k▲
Equity and liabilities
Total equity and liabilities10/49€1.28M€1.28M▼
Equity10/15€505k€505k=
Contributions10/11€5k€5k=
Reserves13€500k€500k=
Distributable reserves133€500k€500k=
Amounts payable17/49€773k€772k▼
Amounts payable after more than one year17€585k€500k▼
Other amounts payable178/9€585k€500k▼
Amounts payable within one year42/48€153k€271k▲
Trade debts44€2k€2k▲
Suppliers440/4€2k€2k▲
Taxes, remuneration and social security45€19k€32k▲
Taxes450/3€18k€32k▲
Remuneration and social security454/9€550-
Other amounts payable47/48€133k€237k▲
Accrued charges and deferred income492/3€35k€1k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€229k€237k▲
Other operating charges640/8€11k€4k▼
Non-recurring operating charges66A€3k-
Gross operating margin9900€433k€562k▲
Operating profit (loss)9901€191k€322k▲
Financial income75/76B€6k€540▼
Recurring financial income75€6k€540▼
Financial charges65/66B€48k€40k▼
Recurring financial charges65€48k€40k▼
Profit (loss) for the period before taxes9903€148k€282k▲
Income taxes67/77€43k€76k▲
Profit (loss) for the period9904€105k€207k▲
Profit (loss) for the period to be appropriated9905€105k€207k▲
Appropriation of the result
Profit (loss) to be appropriated9906€105k€207k▲
Profit to be distributed694/7€105k€207k▲
Return on contributions (dividend)694€105k€207k▲
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €187k | €191k | €208k | €229k | €237k | ▲ 3.5% |
| Other operating charges640/8 | €838 | €12k | €4k | €11k | €4k | ▼ 67.4% |
| Non-recurring operating charges66A | - | - | - | €3k | - | - |
| Gross operating margin9900 | €347k | €504k | €484k | €433k | €562k | ▲ 29.8% |
| Operating profit (loss)9901 | €158k | €301k | €272k | €191k | €322k | ▲ 69.1% |
| Financial income75/76B | - | €2 | - | €6k | €540 | ▼ 91.2% |
| Recurring financial income75 | - | €2 | - | €6k | €540 | ▼ 91.2% |
| Financial charges65/66B | €51k | €40k | €38k | €48k | €40k | ▼ 16.8% |
| Recurring financial charges65 | €51k | €40k | €38k | €48k | €40k | ▼ 16.8% |
| Profit (loss) for the period before taxes9903 | €108k | €261k | €233k | €148k | €282k | ▲ 90.4% |
| Income taxes67/77 | €38k | €87k | €61k | €43k | €76k | ▲ 76.4% |
| Profit (loss) for the period9904 | €70k | €174k | €173k | €105k | €207k | ▲ 96.1% |
| Profit (loss) for the period to be appropriated9905 | €70k | €174k | €173k | €105k | €207k | ▲ 96.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.59M | €1.39M | €1.34M | €1.28M | €1.28M | ▼ 0.1% |
| Fixed assets21/28 | €945k | €862k | €654k | €552k | €328k | ▼ 40.5% |
| Intangible fixed assets21 | €924k | €740k | €557k | €373k | €189k | ▼ 49.2% |
| Tangible fixed assets22/27 | €21k | €121k | €97k | €179k | €139k | ▼ 22.5% |
| Furniture and vehicles24 | €1k | €106k | €84k | €169k | €132k | ▼ 22.1% |
| Other tangible fixed assets26 | €20k | €16k | €13k | €10k | €7k | ▼ 28.9% |
| Current assets29/58 | €640k | €526k | €683k | €726k | €949k | ▲ 30.6% |
| Stocks and contracts in progress3 | €3k | €143 | - | - | - | - |
| Stocks30/36 | €3k | €143 | - | - | - | - |
| Amounts receivable within one year40/41 | - | - | - | €34k | - | - |
| Trade receivables40 | - | - | - | €495 | - | - |
| Other amounts receivable41 | - | - | - | €34k | - | - |
| Current investments50/53 | - | - | - | €202k | - | - |
| Cash at bank and in hand54/58 | €505k | €333k | €478k | €305k | €741k | ▲ 143% |
| Deferred charges and accrued income490/1 | €132k | €193k | €205k | €184k | €208k | ▲ 12.7% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.59M | €1.39M | €1.34M | €1.28M | €1.28M | ▼ 0.1% |
| Equity10/15 | €331k | €505k | €505k | €505k | €505k | = |
| Contributions10/11 | €5k | €5k | €5k | €5k | €5k | = |
| Reserves13 | €326k | €500k | €500k | €500k | €500k | = |
| Distributable reserves133 | €326k | €500k | €500k | €500k | €500k | = |
| Amounts payable17/49 | €1.25M | €883k | €832k | €773k | €772k | ▼ 0.2% |
| Amounts payable after more than one year17 | €1.19M | €760k | €585k | €585k | €500k | ▼ 14.5% |
| Other amounts payable178/9 | €1.19M | €760k | €585k | €585k | €500k | ▼ 14.5% |
| Amounts payable within one year42/48 | €66k | €111k | €245k | €153k | €271k | ▲ 76.4% |
| Trade debts44 | €3k | €732 | €2k | €2k | €2k | ▲ 42.1% |
| Suppliers440/4 | €3k | €732 | €2k | €2k | €2k | ▲ 42.1% |
| Taxes, remuneration and social security45 | €59k | €105k | €69k | €19k | €32k | ▲ 68.7% |
| Taxes450/3 | €56k | €105k | €69k | €18k | €32k | ▲ 73.8% |
| Remuneration and social security454/9 | €3k | - | - | €550 | - | - |
| Other amounts payable47/48 | €5k | €6k | €174k | €133k | €237k | ▲ 77.9% |
| Accrued charges and deferred income492/3 | €3k | €12k | €3k | €35k | €1k | ▼ 96.4% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €70k | €174k | €173k | €105k | €207k | ▲ 96.1% |
| + Depreciation and write-downs630 | €187k | €191k | €208k | €229k | €237k | ▲ 3.5% |
| Operating cash flow (approximation) | €257k | €365k | €381k | €334k | €443k | ▲ 32.7% |
| Investment in fixed assets (approximation) | - | €-108k | €0 | €-127k | €-13k | ▲ 89.8% |
| Change in cash | - | €-171k | €145k | €-173k | €436k | ▲ 351% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
03-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
27-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
17-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
03-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €500kEq €505k ▲52.7%
3 profitable years in a row build equity to €505k.
25-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Weakest financial yearnet €70k ▼72.6%
Net result drops to €70k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity doublescurrent ratio 9.66
Current ratio from 4.50 to 9.66; short-term debt falls from €129k to €66k.
18-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kasterlee · 1 establishment unit since 2020
Ground area
2,039 m²
Building footprint
210 m²
Volume, LiDAR
1,820 m³
Parcel 13017G0019/00L000, Flanders · tallest building 12.1 m, ±3 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
Dr. E. Voets
since 20202.298.495.073
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13017G0019/00L000 | Flanders | 2,039 m² | 1 · 210 m² | 12.1 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR PETRA NIJST - CARDIOLOGIE
BE 0750.648.455
Lanaken · Eq €504,706
Dokters Coenen & Van Laere
BE 0863.322.170
Mechelen · Eq €504,738
LIEVEN PLATTEEUW - GYNAECOLOOG
BE 0691.885.657
Kortrijk · Eq €504,527
COLLETTI GIUSEPPE CARDIOLOGUE
BE 0794.558.870
Arlon · Eq €504,860
P4P Aesthetics
BE 0636.995.634
Braine-l'Alleud · Eq €504,479
Of 16,625 companies in sector 86220 we hold annual accounts for 7,979. 6,425 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded15-01-2020
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Scores and ratios are computed by Checked and are not a credit decision.